New NHS Advice for Polyendocrine Metabolic Ovarian Syndrome (PMOS)
En resumen
- New NHS guidance recommends annual checks for women with Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly Polycystic Ovary Syndrome.
- The condition affects 1 in 8 women and is linked to infertility, irregular periods, and risks like diabetes and heart disease.
- NICE urges faster diagnosis and better monitoring.
Resumen generado por IA
Por qué importa
New draft guidance from health regulator NICE recommends annual checks for women with PMOS, a condition affecting around one in eight women, to better monitor its wide-ranging health issues.
Women with polyendocrine metabolic ovarian syndrome (PMOS) should have annual checks so doctors can spot the wide-ranging health issues that can come with this complex condition, says new advice for the NHS.
PMOS, which affects around one in eight women, used to be known as polycystic ovary syndrome but was renamed in May, external to better reflect the broad impact it can have across the body.
The draft guidance issued by health regulator NICE, external urges faster diagnosis along with better monitoring.
PMOS is a major cause of female infertility. Symptoms can include irregular periods, excessive hair growth and weight gain.
Despite between three and four million women having the condition in the UK, PMOS is still under-diagnosed and inconsistently managed, says NICE.
It recommends the new annual checks cover not just the main symptoms, but also longer-term associated risks, such as diabetes and heart disease.
Lifestyle changes, as well as treatment, could help to prevent more serious illness, says NICE.
There is no cure for PMOS but the NHS already offers treatments, external to manage the symptoms, including hormone support and fertility drugs.
The new guidance is clear that laser and light therapies for hair reduction is not recommended due to the cost.
Sharon Manship has PMOS and was part of the committee that came up with the new guidelines after living with the condition for 30 years.
She said she struggled to get a diagnosis despite having initially sought support in her early 20s for her symptoms. It took her more than 10 years to be told she had PMOS.
"It was so disheartening to be told, until I was finally diagnosed in my mid-30s, that my symptoms were just part of being a woman," she said.
"My hope is that with this new guideline, people with PMOS will be taken seriously, diagnosed earlier and provided with evidence-based support and care from healthcare professionals from the outset, rather than having to go what I went through."
Preguntas abiertas
- When will the final guidance be published?
- What are the specific implementation timelines for NHS trusts?
